These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The challenge to patent law of pure chemical protein synthesis. Fellmeth AX Nat Biotechnol; 2005 May; 23(5):547-9. PubMed ID: 15877067 [No Abstract] [Full Text] [Related]
6. Structural genomics in the biotechnology sector. Dry S; McCarthy S; Harris T Nat Struct Biol; 2000 Nov; 7 Suppl():946-9. PubMed ID: 11103995 [TBL] [Abstract][Full Text] [Related]
7. The end of the beginning for genomic medicine. Bailey D; Zanders E; Dean P Nat Biotechnol; 2001 Mar; 19(3):207-9. PubMed ID: 11231543 [No Abstract] [Full Text] [Related]
8. Sugar added. Cheaper, better protein drugs through sweetening. Gibbs W Sci Am; 2003 Jul; 289(1):23-4. PubMed ID: 12840940 [No Abstract] [Full Text] [Related]
9. Mining the genome for drugs. Wickelgren I Science; 1999 Aug; 285(5430):998-1001. PubMed ID: 10475849 [No Abstract] [Full Text] [Related]
10. Design of site-specific protein drugs. Tomlinson E Sci Total Environ; 1991 Dec; 109-110():9-16. PubMed ID: 1815386 [TBL] [Abstract][Full Text] [Related]
11. Bioinformatics in the pharmaceutical industry. Lyall A Trends Biotechnol; 1996 Aug; 14(8):308-12. PubMed ID: 8987464 [TBL] [Abstract][Full Text] [Related]
18. Recombinant proteins for medical use: the attractions and challenges. Koths K Curr Opin Biotechnol; 1995 Dec; 6(6):681-7. PubMed ID: 8527840 [TBL] [Abstract][Full Text] [Related]
19. Approval times for supplemental indications for recombinant proteins. Gosse ME; Nelson TF Nat Biotechnol; 1997 Feb; 15(2):130-4. PubMed ID: 9035135 [No Abstract] [Full Text] [Related]
20. Information needs and the role of text mining in drug development. Roberts PM; Hayes WS Pac Symp Biocomput; 2008; ():592-603. PubMed ID: 18229718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]